BR9607967A - Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo - Google Patents

Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo

Info

Publication number
BR9607967A
BR9607967A BR9607967A BR9607967A BR9607967A BR 9607967 A BR9607967 A BR 9607967A BR 9607967 A BR9607967 A BR 9607967A BR 9607967 A BR9607967 A BR 9607967A BR 9607967 A BR9607967 A BR 9607967A
Authority
BR
Brazil
Prior art keywords
immunomodular
bile
drug
manufacture
immune system
Prior art date
Application number
BR9607967A
Other languages
English (en)
Inventor
Romeo Rang
Paul B Percheson
Original Assignee
Imutec Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutec Pharma Inc filed Critical Imutec Pharma Inc
Publication of BR9607967A publication Critical patent/BR9607967A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9607967A 1995-03-16 1996-03-13 Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo BR9607967A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40493295A 1995-03-16 1995-03-16
PCT/CA1996/000152 WO1996028175A1 (en) 1995-03-16 1996-03-13 Immunomodulating compositions from bile for the treatment of immune system disorders

Publications (1)

Publication Number Publication Date
BR9607967A true BR9607967A (pt) 1998-01-13

Family

ID=23601619

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607967A BR9607967A (pt) 1995-03-16 1996-03-13 Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo

Country Status (11)

Country Link
US (1) US6596319B2 (pt)
EP (1) EP0814821A1 (pt)
JP (1) JPH11501634A (pt)
KR (1) KR19980703088A (pt)
CN (1) CN1182368A (pt)
AU (1) AU711294B2 (pt)
BR (1) BR9607967A (pt)
CA (1) CA2215339C (pt)
NO (1) NO974257L (pt)
NZ (1) NZ302638A (pt)
WO (1) WO1996028175A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
CA2206047A1 (en) * 1997-05-23 1998-11-23 Romeo Rang (Deceased) Immunomodulating compositions for the treatment of viral disorders
US7799766B2 (en) * 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
WO1999063105A1 (de) * 1998-06-03 1999-12-09 Deutsches Krebsforschungszentrum Stiffung Des Öffentlichen Rechts Glycosyl-inosit-phospho-ceramide (gipc), verfahren zu ihrer herstellung sowie ihre verwendung
WO2002038164A1 (en) * 2000-11-08 2002-05-16 Lorus Therapeutics Inc. Combination preparation of a biological response modifier and an anticancer agent and uses thereof
WO2002102363A1 (en) * 2001-06-20 2002-12-27 Lorus Therapeutics Inc. Biological response modifier composition and uses thereof
WO2005016954A2 (en) * 2003-08-14 2005-02-24 Boston Medical Center Corporation Immunologic activity measure(s) for t “helper” on-associated conditions
US7136936B2 (en) * 2003-10-03 2006-11-14 Asoka Usa Corporation Method and system for virtual powerline local area networks
US7457885B2 (en) * 2005-02-10 2008-11-25 Asoka Usa Corporation Powerline communication system and method using coupler design for additional users
US20050220912A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory composition for treating pelvic endometriosis
EP1863520B1 (en) 2005-03-08 2014-12-31 Aptose Biosciences Inc. Use of interleukin 17e for the treatment of cancer
WO2008085963A1 (en) * 2007-01-05 2008-07-17 University Of Florida Research Foundation, Inc. Materials and methods for the detection, prevention and treatment of autoimmune disease
US8042027B1 (en) 2007-01-16 2011-10-18 Marvell International Ltd. BM/LLR computation for multi-dimensional TCM/BCM
US8236354B1 (en) 2012-02-17 2012-08-07 ZOR Pharmaceuticals, LLC Use of immunomodulators for the treatment of cancer
US8338383B1 (en) 2012-02-17 2012-12-25 Gregory Jr Daniel Tyree Use of immunomodulators for the treatment of cancer
CL2014003632A1 (es) * 2014-12-31 2015-06-26 Pontificia Universidad Católica De Chile Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer.
CN113143936B (zh) * 2021-02-10 2022-03-25 北京蕴汇医药科技有限公司 鹅去氧胆酸或其衍生物在制备egfr和/或stat3的抑制剂中的用途
CN114657125B (zh) * 2022-04-29 2023-08-08 中国科学院海洋研究所 鲨鱼单个核细胞的分离方法、鲨鱼稀释液及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB337797A (en) 1929-07-08 1930-11-10 Henry Leitner A specific for cancer
GB2046092B (en) 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4562179A (en) 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
US4585762A (en) 1982-07-30 1986-04-29 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, processes for use thereof and pharmaceutical composition of the same
JPS5984824A (ja) 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4879226A (en) 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US4767610A (en) 1984-10-19 1988-08-30 The Regents Of The University Of California Method for detecting abnormal cell masses in animals
US4916249A (en) 1985-07-03 1990-04-10 Hans Brachwitz Glycero-3(2)-phospho-L-serine derivatives and salts thereof
IE59777B1 (en) 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
GB8706313D0 (en) 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
US5087721A (en) 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
US4965391A (en) 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5138067A (en) 1987-12-17 1992-08-11 Shionogi & Co. Ltd. Lipid derivatives
EP0356765A3 (en) 1988-08-19 1991-08-07 Takeda Chemical Industries, Ltd. Carboxylic acid derivatives, their production and use
EP0378763A1 (en) 1988-10-27 1990-07-25 Takeda Chemical Industries, Ltd. Lipids, their production and use
GB8909022D0 (en) 1989-04-20 1989-06-07 Cortecs Ltd Pharmaceutical compositions
US5109118A (en) 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8928580D0 (en) 1989-12-19 1990-02-21 Scras 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives
US5369097A (en) 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US5352682A (en) * 1993-03-08 1994-10-04 Digestive Care Inc. Compositions containing salts of bile acid-aminosalicylate conjugates
ES2207639T3 (es) * 1993-09-09 2004-06-01 Lorus Therapeutics Inc. Composiciones modulares inmunologicas a partir de las bilis.
TW342436B (en) 1996-08-14 1998-10-11 Nippon Oxygen Co Ltd Combustion type harm removal apparatus (1)

Also Published As

Publication number Publication date
CA2215339C (en) 1999-01-19
NZ302638A (en) 2001-04-27
AU4873996A (en) 1996-10-02
AU711294B2 (en) 1999-10-07
CN1182368A (zh) 1998-05-20
EP0814821A1 (en) 1998-01-07
WO1996028175A1 (en) 1996-09-19
JPH11501634A (ja) 1999-02-09
KR19980703088A (ko) 1998-09-05
CA2215339A1 (en) 1996-09-19
US6596319B2 (en) 2003-07-22
NO974257D0 (no) 1997-09-15
NO974257L (no) 1997-11-17
US20010009680A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
BR9607967A (pt) Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
EP1254899A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
PT915697E (pt) Anticonvulsionantes derivados do sulfamato uteis no tratamento da obesidade
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
LV11666A (lv) Farmaceitiskie preparati un medikamenti endotelialo traucejumu noversanai un arstesanai
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
DK0909556T3 (da) Rosaceae-ekstrakt som bradykininantagonist
EE9900162A (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
FR2745814B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
DZ1926A1 (fr) Formulations pharmaceutiques.
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
BR9510162A (pt) Medicamento para influenciar afecções da formação óssea
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria
IT1239447B (it) Sistema e dispositivi per la preparazione di prodotti di ricupero da rifiuti e simili in particolare di ammendante agricolo arricchito.
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
PT984786E (pt) Utilizacao das heparinas de baixo peso molecular na prevencao e tratamento do trauma do sistema nervoso central
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.

Legal Events

Date Code Title Description
TC Change of name
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART 36 DA LPI (LEI 9.279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.